Pfizer Inc
NYSE:PFE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Pfizer Inc (PFE) under the Base Case is USD per share.
Compared with the current market price of 29.36 USD, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Pfizer Does
Pfizer is a global drug company that discovers, develops, makes, and sells prescription medicines and vaccines. It sells treatments in areas such as vaccines, cancer, inflammation, rare diseases, internal medicine, and hospital care. Its customers are doctors, hospitals, pharmacies, governments, and health systems that buy and use its products for patients.
- Headquarters
- United States of America US
- Employees
- 75 000
- IPO date
- Jan 17, 1944
Pfizer has a narrow economic moat
Patents and exclusive rights to sell certain medicines prevent rivals from offering direct copies of important Pfizer treatments. These protections let Pfizer earn more than it could if cheaper copies were freely available, although they protect individual products rather than the entire business.
Read the full moat analysis
Revenue & Expenses Breakdown
Pfizer Inc
Earnings Waterfall
Pfizer Inc
What is the Intrinsic Value of one PFE stock?
The intrinsic value for Pfizer Inc (PFE) under the Base Case is USD.
Is PFE stock undervalued or overvalued?
Compared with the current market price of 29.36 USD, the stock appears .
